For tumors with a high proliferation rate in NET G2 (Ki-67 > 5%) and neuroendocrine carcinomas (G3), more frequent follow-up examinations every 2 to 3 months are appropriate. Here, MKI67 is linked to neuroendocrine carcinoma.